Johnson and Johnson Vision Care is a company focused on eye health, operating in the healthcare sector. The company offers services and products aimed at addressing a range of eye health issues, from childhood myopia to presbyopia and cataracts, providing solutions for vision correction and enhancem...
More than 1350 women have won a seven year class action in Australia against the pharmaceutical company Johnson & Johnson over harm they suffered from its transvaginal mesh and tape devices. Federal Court judge Anna Katzmann ruled that Johnson & Johnson's subsidiary Ethicon had sold the products ...
A couple of bumbling private detective siblings get hired to investigate a bar robbery, in this short, low budget, action/comedy send-up of the 1970s "TV private detective" genre. Read more: Plot summary Director Carlos Garcia Writers Carlos Garcia (Story by) | Alfredo E. Rodriguez ...
A new class action against Johnson & Johnson seeks damages and medical monitoring on behalf of women who have been diagnosed with cancer, or might develop it in the future, allegedly as a result of using the company's baby powder and other talc products. Johnson & Johnson says its talc...
Before it's even available, Johnson & Johnson has committed to producing and delivering 1 billion doses of a COVID-19 vaccine. See how they documented the journey and drove amazing engagement with their weekly LinkedIn Live series.
and patents attained by competitors; challenges to patents; changes to applicable laws and regulations, including tax laws and global health care reforms; adverse litigation or government action; changes in behavior and spending patterns or financial distress of purchasers of health care servic...
and development, including uncertainty of clinical success and obtaining regulatory approvals; uncertainty of commercial success for new products; manufacturing difficulties and delays; product efficacy or safety concerns resulting in product recalls or re...
Johnson & Johnson, Civil Action No. 1: 11-CV-00686 (D.D.C.) (E.F.H.) (filed April 8, 2011) JOHNSON & JOHNSON TO PAY MORE THAN $70 MILLION IN SETTLED FCPA ENFORCEMENT ACTION The Securities and Exchange Commission today announced a settlement with Johnson and Johnson ("J&J") to ...
Find the latest comments on Johnson & Johnson (JNJ) stock analysis, from Seeking Alpha's very active community.
and Johnson & Johnson enterprise revenue growth. Johnson & Johnson expects the transaction to be slightly dilutive to neutral to adjusted earnings per share in the first year, considering the impact of financing, and then accretive by approximately $0.05 in 2024, and increasingly accretive thereafter...